11 research outputs found
The cause of two plasma-tail disconnection events in comet P/Halley during the ICE-Halley radial period
A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony
Fifty years of Harper-Dorn creep: a viable creep mechanism or a Californian artifact?
Fifty years ago, in a series of classic creep experiments conducted at the University of California in Berkeley, Harper and Dorn obtained unique experimental data revealing the possibility of a new and heretofore unrecognized flow process occurring in pure aluminum when tested at low stresses and at temperatures very close to the melting temperature. This flow mechanism, subsequently designated Harper–Dorn creep, has been the center of much argument and speculation in the ensuing years. The present paper looks back over the last half-century and charts the various developments in attempts to obtain a more detailed understanding of whether Harper–Dorn creep is (or is not) a viable creep process. Examples are presented for both metals and non-metals. It is concluded that, although it appears Harper–Dorn creep may occur only under restricted conditions associated with high purity materials and low initial dislocation densities, nevertheless there is good evidence supporting the validity of this creep mechanism as a viable and unique flow process
Recommended from our members
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)
BackgroundSurvival from metastatic cutaneous melanoma is substantially lower than for localized disease. Treatments for metastatic melanoma have been limited, but remarkable clinical improvements have been reported in clinical trials in the last decade. We described the characteristics of US patients diagnosed with cutaneous melanoma during 2001-2013 and assessed trends in short-term survival for distant-stage disease.MethodsTrends in 1-year net survival were estimated using the Pohar Perme estimator, controlling for background mortality with life tables of all-cause mortality rates by county of residence, single year of age, sex, and race for each year 2001-2013. We fitted a flexible parametric survival model on the log-hazard scale to estimate the effect of race on the hazard of death because of melanoma and estimated 1-year net survival by race.ResultsOnly 4.4% of the 425 915 melanomas were diagnosed at a distant stage, cases diagnosed at a distant stage are more commonly men, older patients, and African Americans. Age-standardized, 1-year net survival for distant-stage disease was stable at approximately 43% during 2001-2010. From 2010 onward, survival improved rapidly, reaching 58.9% (95% confidence interval = 56.6% to 61.2%) for patients diagnosed in 2013. Younger patients experienced the largest improvement. Survival for distant-stage disease increased in both Blacks and Whites but was consistently lower in Blacks.ConclusionsOne-year survival for distant-stage melanoma improved during 2001-2013, particularly in younger patients and those diagnosed since 2010. This improvement may be a consequence of the introduction of immune-checkpoint-inhibitors and other targeted treatments for metastatic and unresectable disease. Persistent survival inequalities exist between Blacks and Whites, suggesting differential access to treatment
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
Genome-wide association studies (GWAS) have mapped risk alleles for at least 10 distinct cancers to a small region of 63 000 bp on chromosome 5p15.33. This region harbors the TERT and CLPTM1L genes; the former encodes the catalytic subunit of telomerase reverse transcriptase and the latter may play a role in apoptosis. To investigate further the genetic architecture of common susceptibility alleles in this region, we conducted an agnostic subset-based meta-analysis (association analysis based on subsets) across six distinct cancers in 34 248 cases and 45 036 controls. Based on sequential conditional analysis, we identified as many as six independent risk loci marked by common single-nucleotide polymorphisms: five in the TERT gene (Region 1: rs7726159, P = 2.10 Ă— 10(-39); Region 3: rs2853677, P = 3.30 Ă— 10(-36) and PConditional = 2.36 Ă— 10(-8); Region 4: rs2736098, P = 3.87 Ă— 10(-12) and PConditional = 5.19 Ă— 10(-6), Region 5: rs13172201, P = 0.041 and PConditional = 2.04 Ă— 10(-6); and Region 6: rs10069690, P = 7.49 Ă— 10(-15) and PConditional = 5.35 Ă— 10(-7)) and one in the neighboring CLPTM1L gene (Region 2: rs451360; P = 1.90 Ă— 10(-18) and PConditional = 7.06 Ă— 10(-16)). Between three and five cancers mapped to each independent locus with both risk-enhancing and protective effects. Allele-specific effects on DNA methylation were seen for a subset of risk loci, indicating that methylation and subsequent effects on gene expression may contribute to the biology of risk variants on 5p15.33. Our results provide strong support for extensive pleiotropy across this region of 5p15.33, to an extent not previously observed in other cancer susceptibility loci